IN8bio halts phase 2 glioblastoma trial, lays off half of workforce to focus on leukemia cell therapy

IN8bio halts phase 2 glioblastoma trial, lays off half of workforce to focus on leukemia cell therapy dincorvaia Wed, 09/04/2024 - 18:12